FDA inspection
Apicore US LLC: FDA inspection ending Apr 2, 2025
FDA inspection 1266239 · No Action Indicated (NAI) · East Windsor, NJ
Key facts
| Inspection ID | 1266239 |
|---|---|
| Firm | Apicore US LLC |
| FEI number | 3004864046 |
| Address | 148 Princeton Hightstown Rd Ste 300 |
| City | East Windsor |
| State | NJ |
| ZIP | 08520 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Apr 2, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data